Cargando…
The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour
BACKGROUND: The proteolysis-inducing factor (PIF) was identified as a tumour product in various gastrointestinal cancers. A previous study in pancreatic cancer patients suggested PIF expression as a tumour marker, which is not related to tumour size. We hypothesized that PIF could be a useful marker...
Autores principales: | Teich, Niels, Kleeff, Jörg, Lochs, Herbert, Mössner, Joachim, Keim, Volker, Friess, Helmut, Ockenga, Johann |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1184069/ https://www.ncbi.nlm.nih.gov/pubmed/15969757 http://dx.doi.org/10.1186/1471-230X-5-20 |
Ejemplares similares
-
Hereditary chronic pancreatitis
por: Rosendahl, Jonas, et al.
Publicado: (2007) -
Usage characteristics and adverse event rates of the direct puncture and pull techniques for percutaneous endoscopic gastrostomy in patients with malignant tumors of the upper aerodigestive tract
por: Teich, Niels, et al.
Publicado: (2018) -
Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
por: Assfalg, Volker, et al.
Publicado: (2011) -
Cathepsin B cleavage of the trypsinogen activation peptide
por: Teich, Niels, et al.
Publicado: (2002) -
B7-H3 and Its Role in Antitumor Immunity
por: Loos, Martin, et al.
Publicado: (2010)